Analog Devices and Flagship Pioneering announced a strategic alliance to accelerate the development of a fully digitized biological world. This partnership will bridge ADI‘s expertise in engineering for analog and digital semiconductors with Flagship Pioneering’s expertise in applied biology to foster the discovery of biological insights, new and enhanced measurements, diagnostics, and novel interventions. The partnership represents the opportunity to create breakthrough solutions for human health and sustainability. Specifically, the partnership will leverage Flagship Pioneering’s unique innovation process and ADI’s cutting edge semiconductor technologies, signal processing portfolio and physical world domain expertise to unlock deeply disruptive solutions and create new companies in the digital biology space. Initial areas of focus will include bioelectronic platforms, regenerative agriculture, novel applications of AI/ML, and preemptive health and medicine. Potential advancements may further drive next-generation protein sequencing, multiomics, early disease diagnostics, transformation of large biological information to actionable digital data, drug design and optimization, and more. This partnership is the latest in Flagship Pioneering’s Enabling Technologies Initiative, which is focused on the development of new therapeutic modalities by enabling and powering advanced technologies.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADI:
- Analog Devices put volume heavy and directionally bearish
- Analog Devices price target raised to $250 from $235 at Barclays
- Morgan Stanley Pounds the Table on These 2 Quality Large-Cap Stocks
- ClassOne delivers First Solstice system to Analog Devices
- Fly Insider: Zillow, Analog Devices among week’s notable insider trades